LUTEINISING UNRUPTURED FOLLICLE SYNDROME

LUTEINISING UNRUPTURED FOLLICLE SYNDROME was reported 5 times

LUTEINISING UNRUPTURED FOLLICLE SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antirheumatic Agent [EPC] 1 0.0000
1 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
2 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
3 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000